Comparison of proclarix, psa density and mri-erspc risk calculator to select patients for prostate biopsy after mpmri

HIGHLIGHTS

• who: Miriam Campistol et al. from the Department of Surgery, Universitat Autu00f2noma Barcelona, Barcelona, Spain have published the Article: Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI, in the Journal: Cancers 2022, 2702 of 15/01/2018
• what: For these purposes, the authors demonstrate that analysis by PI-RADS category is required.
• how: ROC curves analyzing the efficacy mpMRI MRI-ERSPC RC and Proclarix Proclarix and Overall Performances after theof Selection of PSAD Appropriate Thresholds for the detection of in the overall population . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.